October 31, 2018
Large Pharma companies often turn to CMOs and CDMOs for specialized expertise, while Biotech startups rely upon their labs and hardware, resulting in a rapidly expanding and increasingly global business.
August 30, 2018
Precision medicine and the understanding that every patient is different are driving drug discovery.
June 06, 2018
By better defining addressable patient populations and more precisely predicting likely individual responses, companies are able to reduce a great deal of risk in their clinical trials.
April 26, 2018
The infectious disease space is one of high unmet need. However, this particular market segment carries an additional challenge: drug resistance.
March 27, 2018
The methods of financing biotech R&D are evolving as large pharma companies and governments look to small biotech start-ups to provide the next generation of medicines.
February 22, 2018
Massachusetts offers perhaps the most attractive environment for biopharmaceutical research and development in the world, and is fast closing the gap with its rival supercluster in California.
June 19, 2017
Firms must shift focus from Quality for Compliance to Quality as a Culture by keeping the end patient in mind.
June 19, 2017
Maintaining Safeguards Whilst Lowering Barriers to Market Entry.
May 24, 2017
The cost of developing new drugs and cures is enormous. A delicate balance between encouraging innovation and controlling the cost of medicines has to be maintained.
May 09, 2017
Consolidation and the requirements of new and personalized drugs are changing the playing field.